Equities analysts predict that Bruker Corporation (NASDAQ:BRKR) will announce $381.18 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Bruker Corporation’s earnings, with estimates ranging from $372.70 million to $387.00 million. Bruker Corporation posted sales of $371.70 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 2.6%. The firm is expected to report its next quarterly earnings report after the market closes on Thursday, August 3rd.
On average, analysts expect that Bruker Corporation will report full year sales of $381.18 million for the current financial year, with estimates ranging from $1.65 billion to $1.76 billion. For the next year, analysts expect that the business will report sales of $1.72 billion per share, with estimates ranging from $1.70 billion to $1.74 billion. Zacks’ sales calculations are an average based on a survey of analysts that follow Bruker Corporation.
Bruker Corporation (NASDAQ:BRKR) last released its quarterly earnings results on Wednesday, May 3rd. The medical research company reported $0.19 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.19. The company had revenue of $384.90 million for the quarter, compared to analyst estimates of $372.59 million. Bruker Corporation had a net margin of 9.35% and a return on equity of 26.88%. The firm’s revenue was up 2.5% on a year-over-year basis. During the same quarter last year, the business earned $0.21 earnings per share.
BRKR has been the subject of several research reports. Cleveland Research upgraded shares of Bruker Corporation from a “neutral” rating to a “buy” rating in a research report on Thursday, April 27th. Jefferies Group LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Bruker Corporation in a research report on Friday, May 5th. Zacks Investment Research upgraded shares of Bruker Corporation from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a research report on Thursday, July 6th. BidaskClub downgraded shares of Bruker Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday. Finally, Barclays PLC restated an “equal weight” rating and set a $30.00 price objective (up previously from $26.00) on shares of Bruker Corporation in a research report on Monday, July 17th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $26.46.
In other news, Director Richard Kniss sold 24,000 shares of the stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $28.23, for a total value of $677,520.00. Following the completion of the transaction, the director now owns 46,753 shares in the company, valued at approximately $1,319,837.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Frank H. Laukien purchased 1,920 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was bought at an average price of $25.88 per share, with a total value of $49,689.60. Following the acquisition, the chief executive officer now directly owns 37,712,851 shares in the company, valued at $976,008,583.88. The disclosure for this purchase can be found here. In the last quarter, insiders bought 78,120 shares of company stock valued at $2,047,366 and sold 117,624 shares valued at $3,271,574. Company insiders own 35.20% of the company’s stock.
Several institutional investors have recently made changes to their positions in BRKR. Smithfield Trust Co. bought a new position in shares of Bruker Corporation during the second quarter worth about $138,000. Advisory Services Network LLC bought a new position in shares of Bruker Corporation during the first quarter worth about $150,000. Shaker Investments LLC OH bought a new position in shares of Bruker Corporation during the second quarter worth about $239,000. Capstone Asset Management Co. bought a new position in shares of Bruker Corporation during the first quarter worth about $203,000. Finally, Teacher Retirement System of Texas bought a new position in shares of Bruker Corporation during the first quarter worth about $209,000. Institutional investors and hedge funds own 67.23% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/08/01/381-18-million-in-sales-expected-for-bruker-corporation-nasdaqbrkr-this-quarter.html.
Bruker Corporation (NASDAQ BRKR) traded down 2.62% during mid-day trading on Thursday, reaching $27.93. 510,086 shares of the company traded hands. The firm has a market capitalization of $4.47 billion, a price-to-earnings ratio of 29.71 and a beta of 1.10. Bruker Corporation has a 52 week low of $19.58 and a 52 week high of $30.02. The stock’s 50 day moving average price is $28.70 and its 200 day moving average price is $25.43.
Bruker Corporation declared that its Board of Directors has initiated a share buyback plan on Friday, May 12th that authorizes the company to repurchase $225.00 million in shares. This repurchase authorization authorizes the medical research company to reacquire shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.
Bruker Corporation Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Get a free copy of the Zacks research report on Bruker Corporation (BRKR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
